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Objectives: Perioperative myocardial infarction (MI) has been shown
to increase early and late mortality after vascular surgical (VS) procedures.
We evaluated the frequency and timing of MI after VS and its impact on sur-
vival across a heterogeneous cohort of VS patients.
Methods: All patients undergoing a spectrum of VS (open aortic
resection, endovascular aneurysm repair/thoracic endovascular aortic repair,
carotid endarterectomy/carotid angioplasty and stenting, or lower extrem-
ity bypass) from July 2007 to May 2012 were included. MI was diagnosed
by electrocardiogram changes, elevated troponin, or diagnosis by a cardiol-
ogist. Patients were identiﬁed by Current Procedural Terminology code us-
ing an institutional patient data research registry consisting of
administrative/clinical data and stratiﬁed according to the temporal rela-
tionship of the MI to the indexed procedure (early: #30 days; intermediate:
1 month to 1 year; late: >1 year). Univariate and multivariate methods were
used to identify predictors of MI and its impact on survival.
Results: We identiﬁed 2984 patients who underwent VS during the
study interval. Early MI was observed in 110 (3.7%), intermediate MI in
66 (2.2%), and late MI in 136 (4.5%). Patient age per year (odds ratio
[OR], 1.02; 95% conﬁdence interval [CI], 1.0002-1.05; P¼ .03) and history
of coronary artery disease (CAD; OR, 4.6; 95% CI, 2.8-7.5; P < .01) inde-
pendently predicted risk of early MI. Intermediate MI was predicted by his-
tory of CAD (OR, 3.2; 95% CI, 1.9-5.3; P< .01) and diabetes (OR, 1.7; 95%
CI, 1.1-2.7; P ¼ .02). Procedure type was not predictive of perioperative or
delayed MI. Patients who had an MI within the ﬁrst year had a lower (log-
rank P < .001) survival at 1 year (77% 6 3% vs 92% 6 1%) and 5 years
(61% 6 5% vs 71% 6 2%; Fig). Risk-adjusted (age, gender, CAD, race, hy-
pertension) Cox regression modeling showed that early MI (HR, 1.5; 95%
CI, 1.01-2.2; P ¼ .04) and, more importantly, intermediate MI (HR, 2.2;
95% CI, 1.5-3.2; P< .01) independently predicted increase in late mortality,
whereas late MI had no impact (HR, 1.03; 95% CI, 0.7-1.6; P ¼ .9).
Conclusions: The incidence of MI within the ﬁrst year after major
vascular procedures remains low yet is predicted by a history of CAD and
diabetes. Readily identiﬁable high-risk patients should have focused inten-
sive medical therapy before and after VS.
Fig. Late survival in vascular surgery patients stratiﬁed by MI.
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Clinic, Cleveland, OhioObjectives: Outcomes of reinterventions for failing open mesenteric
reconstructions (ORs) have not been described. Reoperative ORs
(R-ORs) can be challenging because of excessive scar and more advanced
mesenteric disease. The purpose of this study was to evaluate outcomes of
R-ORs and endovascular revascularizations (ERs) in patients with stenosis
or occlusion of ORs.
Methods: We reviewed a cohort of 593 patients treated for chronic
mesenteric ischemia (CMI) in two academic centers from 1991 to 2013.
Clinical data and outcomes of patients treated for failing ORs with R-ORs
or ERs were included in the analysis. Case-control propensity score match-
ing was used to analyze outcomes of R-ORs compared with patients who
underwent their ﬁrst-time ORs for CMI. End points were early and late
mortality, morbidity, patency rates, and freedom from symptom recurrence
and reintervention.
Results: There were 47 patients (5 male, 42 female; mean age, 58 6
13 years) treated by reinterventions for failing ORs. Clinical presentation
was CMI in 38 patients (81%) or acute mesenteric ischemia (AMI) in
nine (19%). Reinterventions included R-ORs in 28 patients (19 CMI and
9 AMI) and ERs in 19, all for CMI. Early mortality was 22% in patients
treated by R-ORs for AMI. There were no early deaths among patients
treated for CMI with R-OR or ER. Early morbidity was 78% for R-ORs
in patients treated for AMI. Morbidity was signiﬁcantly higher for R-ORs
than for ERs in patients with CMI (68% vs 16%; P < .001). Mean
follow-up was 50 6 60 months. Patient survival at 5 years was 60% 6 8%
for the entire cohort. Primary and secondary patency at 1 year was 61% 6
10% and 92% 6 8% for R-ORs and 77% 6 10% and 100% for ERs, respec-
tively, (P ¼ not signiﬁcant). Freedom from symptom recurrence and reinter-
ventions at 1 year was 88% 6 6% and 87% 6 7% for R-ORs and 83% 6 8%
and 71% 6 10% for ERs. Using propensity score matched comparison,
R-ORs were associated with similar mortality, morbidity, patency, recur-
rence, and reintervention rates compared with ﬁrst-time ORs.
Conclusions: Reinterventions for failing open mesenteric reconstruc-
tions using R-OR or ER interventions carry similar mortality, patency, recur-
rence, and reintervention rates. Early morbidity is signiﬁcantly lower with
endovascular compared with R-ORs performed for CMI. Outcomes of R-
ORs are similar to those obtainedwith the ﬁrst timeORs in patientswithCMI.
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Objectives: Retrograde open mesenteric stenting (ROMS) via lapa-
rotomy was introduced as an alternative to surgical bypass in patients with
acute mesenteric ischemia (AMI). The purpose of this study was to evaluate
the indications and outcomes of ROMS for treatment of acute and chronic
mesenteric ischemia (CMI).
Methods: We reviewed the clinical data and outcomes of all consecu-
tive patients treated by ROMS in seven academic centers from 2001 to
2013. ROMS was performed via laparotomy with retrograde access into
the target mesenteric artery and stent placement using a retrograde or ante-
grade approach, or both. End points were early and late (>30 days) mortal-
ity, morbidity, patient survival, patency rates, and freedom from symptom
recurrence and reintervention.
Results: There were 54 patients, 13 male and 41 female, with mean
age of 71 6 11 years. Indications for ROMS were AMI in 44 patients
(81%) and CMI with ﬂush mesenteric occlusions in 10 (19%). Four celiac
axis lesions and 53 superior mesenteric artery lesions were treated by stent-
ing. The mean stent length was 42 6 25 mm. Retrograde mesenteric access
was used in all patients, but 16 required a simultaneous antegrade approach.
The retrograde puncture was closed primarily in 35 patients or with patch
angioplasty in 17 and manual compression in one. Bowel resection was
needed in 29 patients (54%) with AMI because of perforation or gangrene.
Technical success was 98%. One patient was treated by bypass because an
attempted ROMS failed. Early mortality was 41% (18 of 44) for AMI and
10% (1 of 10) for CMI (P < .01). Early morbidity was 73% for AMI and
50% for CMI (P < .01). Mean follow-up was 11 6 19 months. Patient sur-
vival at 1 year was 36% 6 11% for AMI and 68% 6 12% for CMI (P ¼ .29).
For the entire cohort, primary and secondary patency was 65% 6 11% and
